STAT3 and neoplasm: Icaritin administration potently inhibited the growth of the tumor formed by PLC/PRF/5 cells in NOD/SCID mice (Figure 6A), which was accompanied by a reduction of p-Stat3 (Y705) level (Figure 6B).